Breast cancer prognostic factors that affect survival and help guide treatment include: lymph node status, tumor size, estrogen receptor status, and more.| Susan G. Komen®
Hormone Therapy for Metastatic Breast Cancer Watch Susan G. Komen®’s January 2024 MBC Impact Series, Metastatic Breast Cancer and Estrogen Receptor-Positive Breast Cancer. What is hormone therapy? Estrogen and progesterone are female hormones produced in the body. Some breast cancer cells need estrogen and/or progesterone to grow. When these hormones attach to special proteins called […]| Susan G. Komen®
Learn how breast cancer is staged and the stages of breast cancer.| Susan G. Komen®
Hormone receptor status and HER2 status are the main factors in planning breast cancer treatment.| Susan G. Komen®
Learn how hormone therapies can slow or stop the growth of hormone receptor-positive breast cancer tumors by preventing the cancer cells from getting the hormones they need to grow.| Susan G. Komen®